Compare GWH & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GWH | GNTA |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | Italy |
| Employees | 62 | 13 |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 19.9M |
| IPO Year | N/A | N/A |
| Metric | GWH | GNTA |
|---|---|---|
| Price | $0.86 | $0.58 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.25 | N/A |
| AVG Volume (30 Days) | ★ 625.2K | 42.0K |
| Earning Date | 05-07-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.99 | N/A |
| Revenue Next Year | $1,328.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.74 | $0.55 |
| 52 Week High | $13.87 | $10.00 |
| Indicator | GWH | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 38.07 | 40.11 |
| Support Level | N/A | $0.61 |
| Resistance Level | $1.22 | $0.76 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 29.92 | 33.33 |
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. It develops and manufactures long-duration energy storage systems based on iron flow battery technology. The company's batteries use earth-abundant materials, including iron, salt, and water, and are designed for high cycle life and recyclability. It operates as a single business operating segment, which includes all activities related to the design, engineering, and manufacturing of the company's long duration energy storage products. The company's revenue is derived from the sale of its energy storage products and from service contracts.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.